Toronto General Hospital

Toronto ON M5G 2C4

7 studies enrolling now · 29 studies all time

What they study most

ARDS, Adult Gastric Procedures, Adult Gynecological Procedures, Adult Hepato-pancreato-biliary (HPB) Procedures, Adult Lower Gastrointestinal Procedures, Adult Thoracic Procedures, Adult Urological Procedures, Aortic Stenosis, Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation

Studies at this site

• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG — Recruiting now
• Randomization of Single vs Multiple Arterial Grafts — Recruiting now
• Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19) — Recruiting now
• Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection — Recruiting now
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis — Running, not enrolling
• The Merit WRAPSODY AV Access Efficacy Study (WAVE) — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes — Running, not enrolling
• A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy — Completed
• Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• PERIGON Pivotal Trial — Running, not enrolling
• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE — Stopped early
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. — Completed
• Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD — Running, not enrolling
• A Prospective, Single-Arm Multi-Center Study of the HARMONIC® 1100 Shears in Select Devices — Completed
• Acorai Machine Learning Generalization (MLG) Study — Completed
• An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection — Completed
• Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment — Stopped early
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection — Completed
• Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension — Completed
• EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection — Completed